Asembia to Provide HUB and Patient Support Services for MannKind Corporation Related to Afrezza® (insulin human) Inhalation Powder

Thursday, August 11, 2016

FLORHAM PARK, N.J., Aug. 11, 2016 /PRNewswire/ -- Asembia LLC. (Asembia) the industry's leading channel management organization for specialty pharmacy is pleased to announce a new HUB services and patient support program developed collaboratively with MannKind Corporation for Afrezza® (insulin human) Inhalation Powder, a rapid-acting inhaled insulin used to treat adults with diabetes for the control of high blood sugar.

Asembia logo

"We look forward to working with MannKind to support their patients' needs and help them navigate reimbursement challenges and product access for their prescriptions," stated Lawrence Irene, RPh, Chief Executive Officer of Asembia.  Irene continued, "As our HUB services and technology capabilities at Asembia continue to expand, our organization is well-positioned to support brands which require a high-touch approach to ensure optimized patient care and access."

Asembia's comprehensive HUB services program includes end-to-end product support and a web-based prescriber portal which will leverage the latest technology. The program also encompasses full reimbursement support, expert clinical patient outreach services provided through Asembia's URAC accredited call-center operations, prescription triage to a national network of pharmacies and detailed data reporting and analytics. The program has been developed to optimize patient care, prescription delivery and clinical outcomes.

"Utilizing Asembia's comprehensive HUB Services will ensure a white-glove patient experience, and support services that increase patient retention during the first 3 months of treatment and ensure we streamline the prescription process for physicians and patients who are prescribed Afrezza," added Michael Castagna, Chief Commercial Officer of MannKind.

About Asembia

Asembia, LLC (Asembia) is the industry's largest specialty pharmacy group contracting and service organization. Asembia provides comprehensive and cost-effective access to the nation's $100+ billion specialty pharmacy industry. Asembia offers pharmacy providers, manufacturers, health plans and wholesale distributors a total channel management solution through customized patient programs, prescription data management services, online platforms, and unique cost effective purchasing agreements for specialty pharmacy products. Asembia is also the founder and host of the nation's largest annual specialty pharmacy summit. For more information, visit Asembia at www.asembia.com

Christopher Benz

Sr. Director of Business Development

Asembia

P: 973.564.8004

E: chris.benz@asembia.com

Logo - http://photos.prnewswire.com/prnh/20150623/225134LOGO

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/asembia-to-provide-hub-and-patient-support-services-for-mannkind-corporation-related-to-afrezza-insulin-human-inhalation-powder-300312427.html

SOURCE Asembia

TOP